Jacobs Levy Equity Management, Inc Biote Corp. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Biote Corp. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 142,730 shares of BTMD stock, worth $359,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,730
Previous 222,556
35.87%
Holding current value
$359,679
Previous $894,000
52.13%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BTMD
# of Institutions
87Shares Held
15.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$11.5 Million4.62% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$5.76 Million3.0% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$3.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA695KShares$1.75 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $19.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...